Oxford Cannabinoid Ownership
OCTHF Stock | USD 0 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Oxford |
Oxford Pink Sheet Ownership Analysis
About 44.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.41. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Oxford Cannabinoid had not issued any dividends in recent years. Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom. Oxford Cannabinoid is traded on OTC Exchange in the United States.The quote for Oxford Cannabinoid Technologies is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Oxford Cannabinoid Technologies contact John Lucas at 44 20 3034 2820 or learn more at https://www.oxcantech.com.Currently Active Assets on Macroaxis
Other Information on Investing in Oxford Pink Sheet
Oxford Cannabinoid financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford Cannabinoid security.